Effectiveness of inhaled therapies in asthma among adults in Northern Sri Lanka, a low-income and middle-income country: a prospective observational study

Bibliographic Details
Title: Effectiveness of inhaled therapies in asthma among adults in Northern Sri Lanka, a low-income and middle-income country: a prospective observational study
Authors: Shalini Sri Ranganathan, Yalini Guruparan, Thiyahiny S Navaratinaraja, Gowry Selvaratnam
Source: BMJ Open Respiratory Research, Vol 12, Iss 1 (2025)
Publisher Information: BMJ Publishing Group, 2025.
Publication Year: 2025
Collection: LCC:Medicine
LCC:Diseases of the respiratory system
Subject Terms: Medicine, Diseases of the respiratory system, RC705-779
More Details: Background Inhaled corticosteroids (ICS) alone, or combined with long-acting beta2-agonist (LABA), are recommended for chronic asthma. Limited access to inhaled medications hinders effective control of asthma in low-income and middle-income countries.Objective This study aimed to compare the effectiveness of inhaled therapies in a cohort of adult patients with asthma who were receiving treatment in a tertiary hospital in Northern Sri Lanka.Methods A prospective cohort study was conducted among adult patients with asthma on either ICS alone or ICS/LABA combination for at least 3 months. Participants were followed up for 6 months, with two follow-up interviews conducted 3 months apart. The primary outcome measure was asthma control, assessed by a locally validated asthma control patient-reported outcome measure. Secondary outcome measures included the use of short-acting beta2-agonists (SABA) and the percentage of patients required nebulisations and hospitalisations. McNemar’s test was used to determine the statistical significance. A p value≤0.05 was considered significant.Results Of the 1094 participants, 827 (76%) were on ICS monotherapy and 267 (24%) were on ICS/LABA. Though there were no changes in the treatment, progressive improvement in asthma control was observed from baseline to second follow-up in both ICS (54%–72%) and ICS/LABA (76%–81%) groups. Significant improvement in asthma control (p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2052-4439
Relation: https://bmjopenrespres.bmj.com/content/12/1/e002675.full; https://doaj.org/toc/2052-4439
DOI: 10.1136/bmjresp-2024-002675
Access URL: https://doaj.org/article/ea350ad82a1b47ceb5e7d66a21b58969
Accession Number: edsdoj.350ad82a1b47ceb5e7d66a21b58969
Database: Directory of Open Access Journals
More Details
ISSN:20524439
DOI:10.1136/bmjresp-2024-002675
Published in:BMJ Open Respiratory Research
Language:English